Regulation and Antitrust

About ITIF’s Schumpeter Project: Competition Policy for the Innovation Economy
The Schumpeterian perspective represents a new intellectual framework for practical antitrust reforms that enable the innovation economy. That is the mission of ITIF’s Schumpeter Project: to advance dynamic competition policy in which innovation is a central concern for antitrust enforcement, not a secondary consideration.
Read More >>

Led by ITIF’s director of antitrust and innovation policy, Aurelien Portuese, the Schumpeter Project conducts legal and economic research, publishes actionable policy analysis, organizes high-level discussions, and engages with policymakers to rethink the relationship between competition and innovation for the benefit of consumers, innovative companies, the economy, and society. Read more in ITIF’s June 2021 report, “Principles of Dynamic Antitrust: Competing Through Innovation.”

 

Regulation and Antitrust
Check a box to narrow search for individual content items that cover numerous issues.
August 2, 2021
Feedback on Adapting Liability Rules to the Digital Age and Artificial Intelligence
ITIF's Center for Data Innovation responded to the European Commission's call for feedback on its proposals to adapt product liability rules to the digital age.
August 2, 2021
The House’s Antitrust Legislative Package: An Innovation Perspective
The goal of antitrust reform should be to advance a modern approach to competition policy that elevates innovation to become a central concern for antitrust enforcement.
July 26, 2021
Podcast: Chinese Antitrust Exceptionalism, With Dr. Angela Zhang
China leverages antitrust law to achieve industrial policy objectives—including in the tech sectors that are crucial to its rivalry with the United States—but it does so through an insular bureaucracy that is surprisingly fragmented and therefore difficult for outsiders to understand.
July 21, 2021
Senate Hearing Inadvertently Shows Why Antitrust Policy Is the Wrong Prescription for What Ails Drug Markets
Four out of five Americans say prescription drug prices are unreasonably high, according to a recent KFF survey—and people across the political spectrum say pharma profits are a major contributing factor.
July 12, 2021
Reflections on President Biden’s Executive Order on Competition
Few would oppose the president’s stated goals of lowering prices, raising wages, and increasing convenience for Americans. But his executive order is not the way to achieve them.
July 12, 2021
Anticorporate Progressivism: The Movement to Restrict, Restrain, and Replace Big Business in America
For many progressives, anticorporatism is not just the means for achieving other policy goals, it is the main goal in and of itself: an economy rid of large corporations. If their movement prevails, the result will be slower growth, diminished competitiveness, and less opportunity.
July 6, 2021
Antitrust Can Hurt U.S. Competitiveness
When it comes to technology and the economy, the U.S. is grappling with two contradictory goals: competing with China in advanced technology industries and ramping up antitrust enforcement against leading U.S. tech companies.
July 1, 2021
Comments to the FTC on Whether to Rescind Its 2015 Policy Statement on ‘Unfair Methods of Competition’
The FTC has a mandate to determine unfair methods of competition, but the rapidly changing nature of today’s markets should not lead to the FTC adopting precautionary ex-ante rules. The FTC must preserve the dynamic process of creative destruction, not preemptively inhibit it.
June 30, 2021
A Vision for International Antitrust at the WTO
ITIF hosted an expert panel discussion exploring the implications of GTIPA’s declaration of principles, and prospects for the vision to become a reality.
June 29, 2021
Changes to Antitrust Policy Would Harm U.S. Economy
The Europeanization of antitrust policy is overall a terrible idea, but it is nonetheless gaining traction, not just in New York and other states, but in Congress too.

Pages